|
1
|
Laskin JJ and Sandler AB: State of the art
in therapy for non-small cell lung cancer. Cancer Invest.
23:427–442. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Orom UA, Derrien T, Beringer M, Gumireddy
K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q,
et al: Long noncoding RNAs with enhancer-like function in human
cells. Cell. 143:46–58. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhou M, Sun Y, Sun Y, Xu W, Zhang Z, Zhao
H, Zhong Z and Sun J: Comprehensive analysis of lncRNA expression
profiles reveals a novel lncRNA signature to discriminate
nonequivalent outcomes in patients with ovarian cancer. Oncotarget.
7:32433–32448. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou M, Guo M, He D, Wang X, Cui Y, Yang
H, Hao D and Sun J: A potential signature of eight long non-coding
RNAs predicts survival in patients with non-small cell lung cancer.
J Transl Med. 13:2312015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou M, Zhao H, Wang Z, Cheng L, Yang L,
Shi H, Yang H and Sun J: Identification and validation of potential
prognostic lncRNA biomarkers for predicting survival in patients
with multiple myeloma. J Exp Clin Cancer Res. 34:1022015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou M, Xu W, Yue X, Zhao H, Wang Z, Shi
H, Cheng L and Sun J: Relapse-related long non-coding RNA signature
to improve prognosis prediction of lung adenocarcinoma. Oncotarget.
7:29720–29738. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou M, Wang X, Shi H, Cheng L, Wang Z,
Zhao H, Yang L and Sun J: Characterization of long non-coding
RNA-associated ceRNA network to reveal potential prognostic lncRNA
biomarkers in human ovarian cancer. Oncotarget. 7:12598–12611.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou M, Zhao H, Xu W, Bao S, Cheng L and
Sun J: Discovery and validation of immune-associated long
non-coding RNA biomarkers associated with clinically molecular
subtype and prognosis in diffuse large B cell lymphoma. Mol Cancer.
16:162017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yuan SX, Yang F, Yang Y, Tao QF, Zhang J,
Huang G, Yang Y, Wang RY, Yang S, Huo XS, et al: Long noncoding RNA
associated with microvascular invasion in hepatocellular carcinoma
promotes angiogenesis and serves as a predictor for hepatocellular
carcinoma patients' poor recurrence-free survival after
hepatectomy. Hepatology. 56:2231–2241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hutchinson JN, Ensminger AW, Clemson CM,
Lynch CR, Lawrence JB and Chess A: A screen for nuclear transcripts
identifies two linked noncoding RNAs associated with SC35 splicing
domains. BMC Genomics. 8:392007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sasaki YT, Ideue T, Sano M, Mituyama T and
Hirose T: MENepsilon/beta noncoding RNAs are essential for
structural integrity of nuclear paraspeckles. Proc Natl Acad Sci
USA. 106:2525–2530. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sunwoo H, Dinger ME, Wilusz JE, Amaral PP,
Mattick JS and Spector DL: MEN epsilon/beta nuclear-retained
non-coding RNAs are up-regulated upon muscle differentiation and
are essential components of paraspeckles. Genome Res. 19:347–359.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Naganuma T and Hirose T: Paraspeckle
formation during the biogenesis of long non-coding RNAs. RNA Biol.
10:456–461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Choudhry H, Albukhari A, Morotti M, Haider
S, Moralli D, Smythies J, Schödel J, Green CM, Camps C, Buffa F, et
al: Tumor hypoxia induces nuclear paraspeckle formation through
HIF-2α dependent transcriptional activation of NEAT1 leading to
cancer cell survival. Oncogene. 34:45462015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chakravarty D, Sboner A, Nair SS,
Giannopoulou E, Li R, Hennig S, Mosquera JM, Pauwels J, Park K,
Kossai M, et al: The oestrogen receptor alpha-regulated lncRNA
NEAT1 is a critical modulator of prostate cancer. Nat Commun.
5:53832014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nie FQ, Zhu Q, Xu TP, Zou YF, Xie M, Sun
M, Xia R and Lu KH: Long non-coding RNA MVIH indicates a poor
prognosis for non-small cell lung cancer and promotes cell
proliferation and invasion. Tumour Biol. 35:7587–7594. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yap KL, Li S, Muñoz-Cabello AM, Raguz S,
Zeng L, Mujtaba S, Gil J, Walsh MJ and Zhou MM: Molecular interplay
of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by
polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell.
38:662–674. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang F, Huo XS, Yuan SX, Zhang L, Zhou WP,
Wang F and Sun SH: Repression of the long noncoding RNA-LET by
histone deacetylase 3 contributes to hypoxia-mediated metastasis.
Mol Cell. 49:1083–1096. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou M, Zhong L, Xu W, Sun Y, Zhang Z,
Zhao H, Yang L and Sun J: Discovery of potential prognostic long
non-coding RNA biomarkers for predicting the risk of tumor
recurrence of breast cancer patients. Sci Rep. 6:310382016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pan LJ, Zhong TF, Tang RX, Li P, Dang YW,
Huang SN and Chen G: Upregulation and clinicopathological
significance of long non-coding NEAT1 RNA in NSCLC tissues. Asian
Pac J Cancer Prev. 16:2851–2855. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hirose T, Virnicchi G, Tanigawa A,
Naganuma T, Li R, Kimura H, Yokoi T, Nakagawa S, Bénard M, Fox AH
and Pierron G: NEAT1 long noncoding RNA regulates transcription via
protein sequestration within subnuclear bodies. Mol Biol Cell.
25:169–183. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou M, Diao Z, Yue X, Chen Y, Zhao H,
Cheng L and Sun J: Construction and analysis of dysregulated
lncRNA-associated ceRNA network identified novel lncRNA biomarkers
for early diagnosis of human pancreatic cancer. Oncotarget.
7:56383–56394. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma MZ, Chu BF, Zhang Y, Weng MZ, Qin YY,
Gong W and Quan ZW: Long non-coding RNA CCAT1 promotes gallbladder
cancer development via negative modulation of miRNA-218-5p. Cell
Death Dis. 6:e15832015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang R, Ma Y, Yu D, Zhao J and Ma P:
miR-377 functions as a tumor suppressor in human clear cell renal
cell carcinoma by targeting ETS1. Biomed Pharmacother. 70:64–71.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen G, Lu L, Liu C, Shan L and Yuan D:
MicroRNA-377 suppresses cell proliferation and invasion by
inhibiting TIAM1 expression in hepatocellular carcinoma. PLoS One.
10:e01177142015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wen Z, Huang W, Feng Y, Cai W, Wang Y,
Wang X, Liang J, Wani M, Chen J, Zhu P, et al: MicroRNA-377
regulates mesenchymal stem cell-induced angiogenesis in ischemic
hearts by targeting VEGF. PLoS One. 9:e1046662014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bracken AP, Ciro M, Cocito A and Helin K:
E2F target genes: Unraveling the biology. Trends Biochem Sci.
29:409–417. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Takahashi Y, Rayman JB and Dynlacht BD:
Analysis of promoter binding by the E2F and pRB families in vivo:
Distinct E2F proteins mediate activation and repression. Genes Dev.
14:804–816. 2000.PubMed/NCBI
|
|
30
|
Humbert PO, Verona R, Trimarchi JM, Rogers
C, Dandapani S and Lees JA: E2f3 is critical for normal cellular
proliferation. Genes Dev. 14:690–703. 2000.PubMed/NCBI
|
|
31
|
Foster CS, Falconer A, Dodson AR, Norman
AR, Dennis N, Fletcher A, Southgate C, Dowe A, Dearnaley D, Jhavar
S, et al: Transcription factor E2F3 overexpressed in prostate
cancer independently predicts clinical outcome. Oncogene.
23:5871–5879. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sherr CJ and McCormick F: The RB and p53
pathways in cancer. Cancer Cell. 2:103–112. 2002. View Article : Google Scholar : PubMed/NCBI
|
